Myeloid or lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 (Q65174): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Grupo de neoplasias mieloides ou linfoides raras caracterizadas pelo rearranjo dos genes do receptor alfa do fator de crescimento derivado de plaquetas (PDGFRA), do receptor beta do fator de crescimento derivado de plaquetas (PDGFRB) e do receptor 1 do fator de crescimento do fibroblasto (FGFR1), resultando na formação de transcritos de fusão e atividade aberrante da tirosina quinase. A eosinofilia é um achado característico, mas nem sempre está presente. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A group of rare myeloid or lymphoid neoplasms characterised by rearrangement of the platelet-derived growth factor receptor alpha (PDGFRA), platelet-derived growth factor receptor beta (PDGFRB), and fibroblast growth factor receptor-1 (FGFR1) genes, resulting in the formation of fusion transcripts and aberrant tyrosine kinase activity. Eosinophilia is a characteristic finding but it is not always present. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/773550674 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_773550674 | |||||||||||||||
| Property / CURIE: CID11:ID_773550674 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_773550674 | |||||||||||||||
| Property / Canary Token: dki-india-ID_773550674 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:53, 14 August 2026
A group of rare myeloid or lymphoid neoplasms characterised by rearrangement of the platelet-derived growth factor receptor alpha (PDGFRA), platelet-derived growth factor receptor beta (PDGFRB), and fibroblast growth factor receptor-1 (FGFR1) genes, resulting in the formation of fusion transcripts and aberrant tyrosine kinase activity. Eosinophilia is a characteristic finding but it is not always present.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_773550674 |
||
| English | Myeloid or lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 |
A group of rare myeloid or lymphoid neoplasms characterised by rearrangement of the platelet-derived growth factor receptor alpha (PDGFRA), platelet-derived growth factor receptor beta (PDGFRB), and fibroblast growth factor receptor-1 (FGFR1) genes, resulting in the formation of fusion transcripts and aberrant tyrosine kinase activity. Eosinophilia is a characteristic finding but it is not always present. |
Statements
CID11:ID_773550674
0 references
dki-india-ID_773550674
0 references
Concluído
0 references
13 August 2026
0 references
